These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 23411683)

  • 21. Insights into the structure and tubulin-targeted anticancer potential of N-(3-bromobenzyl) noscapine.
    Cheriyamundath S; Mahaddalkar T; Reddy Nagireddy PK; Sridhar B; Kantevari S; Lopus M
    Pharmacol Rep; 2019 Feb; 71(1):48-53. PubMed ID: 30465924
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Biological characteristics of microtubule and related drug research].
    Li JN; Jiang JD
    Yao Xue Xue Bao; 2003 Apr; 38(4):311-5. PubMed ID: 12889136
    [No Abstract]   [Full Text] [Related]  

  • 23. Taccalonolides: Novel microtubule stabilizers with clinical potential.
    Risinger AL; Mooberry SL
    Cancer Lett; 2010 May; 291(1):14-9. PubMed ID: 19880245
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dendrimer-stabilized smart-nanoparticle (DSSN) platform for targeted delivery of hydrophobic antitumor therapeutics.
    Tekade RK; Tekade M; Kumar M; Chauhan AS
    Pharm Res; 2015 Mar; 32(3):910-28. PubMed ID: 25205461
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Microtubule active agents: beyond the taxane frontier.
    Morris PG; Fornier MN
    Clin Cancer Res; 2008 Nov; 14(22):7167-72. PubMed ID: 19010832
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Vinflunine, a new vinca alkaloid: cytotoxicity, cellular accumulation and action on the interphasic and mitotic microtubule cytoskeleton of PtK2 cells.
    Jean-Decoster C; Brichese L; Barret JM; Tollon Y; Kruczynski A; Hill BT; Wright M
    Anticancer Drugs; 1999 Jul; 10(6):537-43. PubMed ID: 10885901
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Potential antagonism of tubulin-binding anticancer agents in combination therapies.
    Taraboletti G; Micheletti G; Dossi R; Borsotti P; Martinelli M; Fiordaliso F; Ryan AJ; Giavazzi R
    Clin Cancer Res; 2005 Apr; 11(7):2720-6. PubMed ID: 15814654
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Polymeric micelles with water-insoluble drug as hydrophobic moiety for drug delivery.
    Li G; Liu J; Pang Y; Wang R; Mao L; Yan D; Zhu X; Sun J
    Biomacromolecules; 2011 Jun; 12(6):2016-26. PubMed ID: 21568262
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of drugs affecting microtubular assembly on microtubules, phospholipid synthesis and physiological indices (signalling, growth, motility and phagocytosis) in Tetrahymena pyriformis.
    Kovács P; Csaba G
    Cell Biochem Funct; 2006; 24(5):419-29. PubMed ID: 15912561
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tubulin: an example of targeted chemotherapy.
    Seligmann J; Twelves C
    Future Med Chem; 2013 Mar; 5(3):339-52. PubMed ID: 23464522
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Sterically stabilized gelatin microassemblies of noscapine enhance cytotoxicity, apoptosis and drug delivery in lung cancer cells.
    Madan J; Pandey RS; Jain UK; Katare OP; Aneja R; Katyal A
    Colloids Surf B Biointerfaces; 2013 Jul; 107():235-44. PubMed ID: 23502046
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Diverse approaches for the enhancement of oral drug bioavailability.
    Fasinu P; Pillay V; Ndesendo VM; du Toit LC; Choonara YE
    Biopharm Drug Dispos; 2011 May; 32(4):185-209. PubMed ID: 21480294
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Self-emulsifying drug delivery systems (SEDDS) for improved oral delivery of lipophilic drugs.
    Gursoy RN; Benita S
    Biomed Pharmacother; 2004 Apr; 58(3):173-82. PubMed ID: 15082340
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A new culture model facilitating rapid quantitative testing of mitotic spindle inhibition in mammalian cells.
    De Brabander M; Van de Veire R; Aerts F; Geuens S; Hoebeke J
    J Natl Cancer Inst; 1976 Feb; 56(2):357-63. PubMed ID: 1255766
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inclusion complexes of noscapine in beta-cyclodextrin offer better solubility and improved pharmacokinetics.
    Madan J; Dhiman N; Parmar VK; Sardana S; Bharatam PV; Aneja R; Chandra R; Katyal A
    Cancer Chemother Pharmacol; 2010 Feb; 65(3):537-48. PubMed ID: 19597818
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Molecular docking and pharmacogenomics of vinca alkaloids and their monomeric precursors, vindoline and catharanthine.
    Sertel S; Fu Y; Zu Y; Rebacz B; Konkimalla B; Plinkert PK; Krämer A; Gertsch J; Efferth T
    Biochem Pharmacol; 2011 Mar; 81(6):723-35. PubMed ID: 21219884
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Indibulin, a novel microtubule inhibitor, discriminates between mature neuronal and nonneuronal tubulin.
    Wienecke A; Bacher G
    Cancer Res; 2009 Jan; 69(1):171-7. PubMed ID: 19118000
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Novel pH-sensitive supramolecular assemblies for oral delivery of poorly water soluble drugs: preparation and characterization.
    Sant VP; Smith D; Leroux JC
    J Control Release; 2004 Jun; 97(2):301-12. PubMed ID: 15196757
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Formulation approaches to improving the delivery of an antiviral drug with activity against seasonal flu.
    Sammeta SM; Wang L; Mutyam SK; O'Loughlin K; Green CE; Werner MH; Kelly T; Shankar GN
    Pharm Dev Technol; 2015 Mar; 20(2):169-75. PubMed ID: 24218989
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inhibition of microtubule formation by uremic toxins: action mechanism and hypothesis about the active component.
    Braguer D; Gallice P; Monti JP; Murisasco A; Crevat A
    Clin Nephrol; 1986 Apr; 25(4):212-8. PubMed ID: 3698354
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.